Titoli del Settore Sanitario
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1 |  LLY Eli Lilly & Co. | 929.23 USD | -1.09% | +0.51% | -6.41% | +23.73% | 876.60 B USD | ||
| 2 |  JNJ Johnson & Johnson | 237.91 USD | -0.20% | -1.09% | -2.50% | +56.94% | 573.34 B USD | ||
| 3 |  ABBV ABBVIE INC. | 205.81 USD | -1.06% | -0.08% | -6.92% | +15.99% | 363.91 B USD | ||
| 4 |  MRK Merck & Co., Inc. | 120.22 USD | -0.99% | +0.55% | +4.23% | +50.24% | 297.23 B USD | ||
| 5 |  NVS Novartis AG | 154.35 USD | +0.25% | +1.91% | +0.19% | +44.02% | 294.52 B USD | ||
| 6 |  UNH UNITEDHEALTH GROUP INCORPORATED (Delaware) | 310.96 USD | +2.15% | +0.84% | +9.38% | -47.74% | 282.25 B USD | ||
| 7 |  TMO Thermo Fisher Scientific, Inc. | 510.71 USD | +2.95% | +5.44% | +8.57% | +14.12% | 189.72 B USD | ||
| 8 |  AMGN Amgen Inc | 349.82 USD | -0.34% | +2.83% | -5.30% | +22.05% | 188.58 B USD | ||
| 9 |  ABT Abbott Laboratories | 100.55 USD | +0.27% | -1.32% | -7.62% | -21.17% | 174.72 B USD | ||
| 10 |  GILD Gilead Sciences Inc | 139.03 USD | 0.00% | +0.02% | -3.61% | +33.71% | 172.59 B USD | ||
| 11 |  ISRG Intuitive Surgical Inc. | 458.96 USD | +1.85% | +1.76% | -3.03% | -9.32% | 162.99 B USD | ||
| 12 |  PFE Pfizer Inc. | 27.49 USD | +2.16% | -0.69% | +2.96% | +24.50% | 156.32 B USD | ||
| 13 |  DHR Danaher Corporation | 195.36 USD | +3.03% | +2.17% | +3.26% | +1.70% | 138.15 B USD | ||
| 14 |  SYK Stryker Corporation | 346.39 USD | +2.12% | +4.97% | +2.15% | -2.08% | 132.56 B USD | ||
| 15 |  GSK GSK plc American Depositary Shares (Each representing two Ordinary Shares) | 58.8900 USD | +1.17% | +5.35% | +8.57% | +34.30% | 127.07 B USD | ||
| 16 |  BMY Bristol-Myers Squibb Co. | 58.09 USD | -0.90% | -1.74% | -2.29% | +12.73% | 118.30 B USD | ||
| 17 |  SNY Sanofi American Depositary Shares (Each representing one-half of one ordinary share) | 46.96 USD | +0.43% | -0.28% | +6.85% | -8.66% | 114.53 B USD | ||
| 18 |  MDT Medtronic plc | 87.9610 USD | +0.91% | +2.21% | +0.61% | -6.25% | 112.93 B USD | ||
| 19 |  VRTX Vertex Pharmaceuticals Inc | 440.05 USD | +0.87% | +1.04% | -7.39% | -9.51% | 111.79 B USD | ||
| 20 |  HCA HCA Healthcare, Inc. | 494.91 USD | -0.11% | +2.40% | -7.47% | +47.05% | 110.67 B USD |
Notizie Titoli del Settore Sanitario
Undercovered Stocks: Zscaler, Aeluma, Devon Energy, And More
Travere Therapeutics, Inc. (TVTX) Discusses FDA Approval of FILSPARI as First Approved Medicine for FSGS Transcript
Travere Therapeutics, Inc. (TVTX) Discusses FDA Approval of FILSPARI as First Approved Medicine for FSGS - Slideshow (NASDAQ:TVTX) 2026-04-13
ADBE, ADSK, VEEV: Michael Burry Loads Up on Beaten-Down Software Stocks - TipRanks.com
Mineralys Therapeutics MLYS: il direttore medico vende azioni per 59.000 dollari
Teva Stock: The Market Is Pricing The Past, Not The Pipeline - Initiating Buy (NYSE:TEVA)
Phreesia: Hoffman vende azioni per 116.877 dollari
Gainers Titoli del Settore Sanitario
 QNCX Quince Therapeutics, Inc. Common Stock | 1.41 | +907.14% |
 AKAN Akanda Corp. Common Shares | 3.01 | +377.78% |
 RVMDW Revolution Medicines, Inc. Common Stock | 4.4100 | +123.86% |
 NRXPW NRX Pharmaceuticals, Inc. Common Stock | 0.0120 | +87.50% |
 VRAX Virax Biolabs Group Limited Ordinary Shares | 0.17 | +70.00% |
 RVMD Revolution Medicines, Inc. Common Stock | 136.3000 | +41.35% |
 GCTK GlucoTrack, Inc. Common Stock | 0.8780 | +32.11% |
 HURA TuHURA Biosciences, Inc. Common Stock | 2.87 | +26.43% |
Losers Titoli del Settore Sanitario
 REPL Replimune Group, Inc. | 1.70 | -64.29% |
 WORX SC WORX Corp | 1.06 | -30.72% |
 ONCO Onconetix, Inc. Common Stock | 0.8000 | -26.61% |
 XAIR Beyond Air, Inc. Common Stock | 0.63 | -18.18% |
 QSIAW Quantum-Si Incorporated Class A Common Stock | 0.0900 | -17.20% |
 ZNTL Zentalis Pharmaceuticals, Inc. Common Stock | 5.56 | -15.89% |
 CLGN CollPlant Biotechnologies Ltd Ordinary Shares | 0.32 | -15.79% |
 BFRIW Biofrontera Inc. Common Stock | 0.0400 | -15.61% |